📰 Presents News
Page 167 - Presents News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Presents. Real-time updates on events, politics, business and more.
June 5, 2022
As "embarrassing," and says he has plans for new sculptures that reflect this view. all i want for christmas is you is one of the most successful christmas singles of all time but now, 28 years after its release, mariah carey and her co—writer are facing a $20 million lawsuit. songwriter andy stone accuses them of exploiting a song he co—wrote in 1989 which had the same name. lets have a listen to the song youve most probably heard before. # 0ooh, yeah. # i dont want a lot for christmas. # t...
June 5, 2022
Data show MammaPrint is the first and most comprehensive FDA-cleared test for early breast cancer resulting in the ability to identify women who may be over- or under-treated if treatment decisions
June 5, 2022
90% of patients achieve tumor size reductions 40% of patients achieve partial response, i.e. tumor size reductions of more than 50% Regulatory News: NOXXON Pharma N.V. (Euronext Growth
June 5, 2022
34% overall response rate in 79 evaluable patients with measurable disease9.1 months median duration of responseTumor reduction in 70% of patientsZeno observed to be very well-toleratedPotential new standard
June 4, 2022
Accra [Ghana]/ Mumbai (Maharashtra) [India], June 4 (ANI/BusinessWire India): Merck Foundation, the philanthropic arm of Merck KGaA Germany has released the Fourth Episode of their TV program - Our Africa by Merck Foundation on Sunday, May 29, 2022, on GH One, Ghana
June 4, 2022
Results indicate that SPI-62 has the potential to mitigate adverse effects of glucocorticoid medications Sparrow Pharmaceuticals, an emerging, clinical-stage biopharmaceutical company developing
June 4, 2022
Data demonstrate Research Use Only ImPrint test's ability to identify patients with high risk early breast cancer who may benefit from PD-1/PD-L1 checkpoint inhibition Agendia, Inc., a commercial-stage
June 3, 2022
WESTON (dpa-AFX) - At the Annual European Congress of Rheumatology on Friday, biotechnology companies Biogen Inc. (BIIB) and Bio-Thera Solutions, Ltd. presented positive Phase 3 data for BIIB800
June 3, 2022
How Environmental Consciousness Hits the Game IndustryThis press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220603005478/en/Endling: Extinction
June 3, 2022
(PLX AI) - Bayer to present new Kerendia (finerenone) data from comprehensive clinical trial program across a broad range of patients with chronic kidney disease and type 2 diabetes at the 2022 American